NJK PHARMA

What NJK PHARMA does

NJK Pharmacy Pvt Ltd, operating as NJK Pharma, is a Chennai-headquartered, privately held Indian pharmaceutical and wellness company founded in 2019 and operational since 2020. The company operates four business divisions covering general pharmaceuticals (including APIs and essential medicines), beauty and personal care (Glow by NJK), dermatology and cosmetology (NJK Derma), and cardio-diabetic care (Dia-Life), with three additional divisions reportedly planned. Its product portfolio spans 149+ dosage forms and 200+ SKUs, including formulations such as tablets, capsules, injectables, syrups, and ointments, alongside branded supplements (Magnitop, Ascozine D3, Maalife, Fesugain XT, Livervita). Magnitop is positioned as India's first magnesium effervescent tablet, representing the company's most notable formulation differentiator.

NJK Pharma conducts R&D across specialty drugs, generics, APIs, and New Drug Delivery Systems, with capabilities spanning formulation development, process chemistry, analytical development, and preclinical/clinical research, and manufactures at WHO-cGMP certified facilities. The company distributes prescription drugs (NOTC) and OTC medicines through a network of medical representatives and pharmacies across Tamil Nadu, with limited disclosed geographic presence beyond that single Indian state. Direct-to-consumer e-commerce is operated through dedicated brand websites (magnitop.in and glowbynjk.com), and the company markets strategic retail, pharma, business development, and sponsorship partnerships as growth vectors.

The business model is one-time product sales across prescription drugs, branded generics, OTC medicines, supplements, and beauty/personal care products, with revenue split across hospitals, pharmacies, and end consumers. The company is founder-controlled, with Dr. J Sri Nisha as Chairperson (also chairperson of the Sree Balaji Group of Institutions) and Dr. Gopi Ayyaswamy as CEO since 2020. No institutional investors, parent company, or funding rounds are disclosed; in 2025 the company announced cross-border partnership alliances in healthcare, wellness, and pharmaceuticals. No revenue, pricing, or financial figures are publicly disclosed, and the company carries no disclosed AI capabilities, APIs, or software products.

Name

NJK PHARMA

Legal name

NJK Pharmacy Pvt Ltd

Website

https://njkpharma.com

Company type

Private

Founded year

2019

Operating status

Operating

Headcount range

11–50 employees

Short description

NJK Pharma is a privately held Chennai-based pharmaceutical and wellness company operating four divisions — general pharma, beauty (Glow by NJK), dermatology (NJK Derma), and cardio-diabetic care (Dia-Life) — distributing prescription drugs, OTC medicines, supplements, and beauty products to hospitals, pharmacies, and consumers primarily in Tamil Nadu, India.

Ownership category

akta.pro rank

Product category

Pharmaceutical Manufacturing

NAICS

Pharmaceutical Preparation Manufacturing (325412), Pharmaceutical and Medicine Manufacturing (3254)

SIC

Pharmaceutical Preparations (2834), Medicinal Chemicals & Botanical Products (2833)

akta.pro primary industry

Primary Care & General Medicine Pharmaceuticals (HLAIAAAA)

akta.pro secondary industries

Cardiometabolic Pharmaceuticals (Cardiovascular/Diabetes/Obesity) (HLAIAAAE), Dermatology & Aesthetics Pharmaceuticals (HLAIAAAK), Compounding Ingredient & API Distributors (Pharma Supply) (HLAIAJAO), Vitamins & Minerals (Single Nutrients) (CRADAGAB)

Keywords

• Pharmaceutical manufacturing
• Generic medicines
• Cardio-diabetic care
• Dermatology products
• Beauty supplements

Headquarters

HQ city

Chennai

HQ country

India

HQ region

Asia

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Technology or R&D, Supply Chain, Operations, Marketing or Sales, Infrastructure

Revenue model

1. Pharmaceutical Products Sales: NJK Pharma generates revenue through sale of prescription drugs (NOTC - Not-Over-The-Counter), OTC medicines, branded generics, and supplements across their four business divisions. Products are distributed through hospitals, pharmacies, and medical representatives.
2. Beauty and Personal Care Products: Revenue from Glow by NJK beauty and personal care division, including skincare and cosmetology products sold through retail and e-commerce channels.
3. Specialized Healthcare Products: Revenue from specialized divisions including Dia-Life (cardio-diabetic care), NJK Derma (dermatology), and supplements like Magnitop, Ascozine D3, Maalife, Fesugain XT, and Livervita.

Go-to-market motion2 records

Distribution channels3 records

Marketing channels3 records

Core offering

NJK Pharma manufactures and sells pharmaceutical products across four business divisions: General Pharma (essential medicines, APIs, NOTC prescription drugs, and OTC products for hospitals and pharmacies), Glow by NJK (beauty and personal care products), NJK Derma (skincare and cosmetology solutions), and Dia-Life (cardio-diabetic care products). The company also markets science-backed wellness supplements including Magnitop — India's first magnesium effervescent tablet — and distributes through medical representatives, pharmacies, and brand-specific e-commerce websites.

Product overview

NJK Pharma is a multi-division pharmaceutical and wellness company offering a diversified portfolio of healthcare products across four business divisions. The company provides Over-The-Counter (OTC) medicines, Branded Generics ensuring affordability, science-backed supplements, and innovative Beauty and Personal Care products. Key divisions include General Pharma (essential medications and APIs), Glow by NJK (beauty and personal care), NJK Derma (skincare and cosmetology), and Dia-Life (cardio-diabetic care). Notable products include Magnitop (India's 1st Magnesium effervescent tablet), Ascozine D3, Maalife, Fesugain XT, and Livervita supplements. The portfolio spans 149+ dosage forms, 40+ wellness and beauty products, and 11+ supplements.

Differentiator

Problem solved

Functional benefit

Brands

• Glow by NJK: Beauty and Personal Care Division dedicated to enhancing natural beauty and promoting personal well-being with innovative and quality products.
• NJK Derma
• Dia-Life
• Magnitop
• General Pharma

Products and services

• Glow by NJK (Beauty & Personal Care Division) Beauty and personal care product line offering innovative, quality products designed to enhance natural glow and nourish skin, available through retail channels and the dedicated glowbynjk.com e-commerce site.
• Magnitop India's first magnesium effervescent tablet, a wellness supplement offering rapid absorption, enhanced patient compliance, and a seamless healthcare experience for energy, vitality, and well-being. Sold through pharmacies and the dedicated magnitop.in e-commerce site.
• NJK Derma (Skincare & Cosmetology Division) Specialized dermatology and cosmetology product line committed to addressing various skin health needs with effective and innovative products backed by scientific understanding.
• Dia-Life (Cardio & Diabetic Care Division) Cardio and diabetic care product line offering specialized products and resources aimed at improving the quality of life for individuals managing cardiovascular health and diabetes.
• General Pharma General pharmaceutical division providing high-quality Active Pharmaceutical Ingredients (APIs), NOTC prescription drugs, and OTC medicines, serving hospitals and pharmacies across Tamil Nadu through a network of medical representatives.
• Ascozine D3 Supplement brand within NJK's wellness portfolio supporting health and wellness.
• Maalife Wellness supplement brand within the NJK portfolio.
• Fesugain XT Health supplement brand within the NJK portfolio.
• Livervita Health supplement brand within the NJK portfolio supporting liver health.

Segments5 records

Ideal customer profiles5 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

Two partnerships are on record, tiered core.

• Cross-border Partnership AlliancescoreStrategic or Co-development Partner · 1 January 2025Strategic cross-border partnership alliances across healthcare, wellness, and pharmaceutical sectors announced in 2025 as part of the company's strategic evolution. These alliances focus on advancing sustainable healthcare solutions and positioning NJK as an influential voice in the pharmaceutical sector.
• Medical Colleges, Universities, and HospitalscoreStrategic or Co-development PartnerStrong affiliations with Medical Colleges, Universities, and Hospitals providing NJK Pharma with a robust research ecosystem. These partnerships fuel potential research collaborations, ensure a consistent pipeline of skilled talent, and strengthen internal expertise contributing to API industry advancement.

Scale indicators9 records

Recent moves6 records

Expansion highlights5 records

Broad incumbents

• Cipla: One of India's largest pharma companies with broad prescription, OTC, and API exposure including cardio-respiratory and dermatology. Overlaps NJK's therapeutic categories but at vastly larger scale and global footprint.
• Sun Pharmaceutical Industries: India's largest pharma company and a global specialty generics leader with extensive dermatology, cardio-metabolic, and OTC franchises. Represents the upper-bound incumbent benchmark for NJK's therapeutic and category ambitions.
• Zydus Lifesciences (Cadila Healthcare): Indian pharma major with APIs, formulations, wellness, and consumer healthcare divisions. Comparable architectural similarity to NJK's multi-division structure but at much greater scale and with established international presence.
• Emami: Indian FMCG-major in personal care, beauty, and wellness OTC with a strong dermatology adjacency. Comparable to Glow by NJK and NJK Derma divisions in consumer-facing beauty and personal care distribution.

Direct peers

• Alkem Laboratories: Indian pharma manufacturer with branded generics and OTC presence across multiple therapy areas, including cardio-metabolic and dermatology. Comparable in product mix, India-centric distribution, and growing supplement portfolio.
• Torrent Pharmaceuticals: Mid-sized Indian pharma with strong branded generics portfolio across cardio-diabetic, dermatology, and general therapy — overlapping NJK's Dia-Life and NJK Derma divisions. Operates medical-rep-driven sales model similar to NJK.
• Himalaya Wellness: Indian wellness company with pharma-grade manufacturing, dermatology/cosmetics, and supplement brands overlapping NJK's Glow by NJK, NJK Derma, and supplement lines. Comparable as an India-based, multi-category health and beauty manufacturer.
• Glenmark Pharmaceuticals: Indian-headquartered pharma with branded generics, derma franchise, and emerging OTC/specialty portfolio. Comparable in therapeutic breadth and India-first commercial focus with selective international expansion.
• Mankind Pharma: India's largest domestic pharma company by prescription share, with a similar branded generics, OTC, and supplement portfolio across multiple therapeutic categories. Highly comparable in GTM via medical representatives and pan-India pharmacy distribution.
• Micro Labs: Private Indian pharma company with broad branded generics and OTC portfolio spanning cardio, dermatology, and general therapy. Closest comparable as a private, multi-division, India-domestic pharma player with similar revenue scale.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/njk-pharma-private-limited

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about NJK PHARMA